Mosaic Family Wealth’s Intellia Therapeutics NTLA Stock Holding History

Mosaic Family Wealth’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-535	Closed	-$9K	–	456
2019 Q1	$9K	Hold	535	–	–	﹤0.01%	508
2018 Q4	$7K	Hold	535	–	–	﹤0.01%	526
2018 Q3	$10K	Hold	535	–	–	﹤0.01%	499
2018 Q2	$15K	Hold	535	–	–	0.01%	490
2018 Q1	$11K	Hold	535	–	–	﹤0.01%	514
2017 Q4	$10K	Hold	535	–	–	﹤0.01%	530
2017 Q3	$13K	Hold	535	–	–	0.01%	543
2017 Q2	$9K	Hold	535	–	–	﹤0.01%	517
2017 Q1	$8K	Hold	535	–	–	﹤0.01%	527
2016 Q4	$7K	Buy	+535	New	+$8.04K	﹤0.01%	520

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mosaic Family Wealth's NTLA Position: Q2 2019 in Review

Mosaic Family Wealth sold out of Intellia Therapeutics (NTLA) in Q2 2019, closing a stake of 535 shares — an estimated $9K sold.

Mosaic Family Wealth first reported a position in NTLA in Q4 2016 and held it in 10 quarters. The position peaked at $15K in Q2 2018. 144 funds tracked by Wall St. Rank hold NTLA as of Q2 2019.

Mosaic Family Wealth reported no remaining Intellia Therapeutics position as of Q2 2019 after selling out during the quarter.
Mosaic Family Wealth sold 535 Intellia Therapeutics shares in Q2 2019, an estimated $9K.
Mosaic Family Wealth first reported a position in Intellia Therapeutics in Q4 2016 and held it in 10 quarters.
Mosaic Family Wealth's Intellia Therapeutics position peaked at $15K in Q2 2018.
144 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2019.

Based on Mosaic Family Wealth's 13F filing for Q2 2019, filed 12 Aug 2019.